ITGB7 and Miyoshi myopathy: Oncogenic overexpression of integrin-β7 (ITGB7) in high-risk MM has been reported to enhance interactions between neoplastic plasma cells and stromal cells, thereby promoting cell-adhesion-mediated drug resistance.